Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial
JAMA 2019 Sep 19;322(12)1155-1166, J Rosenstock, SE Kahn, OE Johansen, B Zinman, MA Espeland, HJ Woerle, E Pfarr, A Keller, M Mattheus, D Baanstra, T Meinicke, JT George, M von Eynatten, DK McGuire, N MarxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.